DIAGNOSTIC DELAY IN PATIENTS DIAGNOSED WITH CUTANEOUS MALIGNANT MELANOMA
Author(s)
Horváthné Kívés Z1, Boncz I1, Gyuró M1, Vajda R1, Sándor J2
1University of Pécs, Pécs, Hungary, 2University of Debrecen, Debrecen, Hungary
OBJECTIVES: The aim of the present study was to assess the diagnostic delay and the associated factors in patients with cutaneous malignant melanoma. METHODS: We carried out a survey including medical record analysis in patients diagnosed within five years with cutaneous malignant melanoma at the Pécs Dermatological Clinic (n=362).The study investigated the diagnostic delay, its risk factors as clinical and histological characteristics of the tumor, and patients’ sociodemographic factors. Chi-square test, Mann-Whitney U test, and Kruskall-Vallis test was used with 95% probability level (p<0.05). RESULTS: relatives to examine themselves. The most common site of prevalence was the lower limb in females (78.5% of cases); the trunk in males (61.3% of cases) (p<0.001). The most common symptom observed by patients was the increase in lesion size (50.3%). Its prevalence on the lower limb (p=0.01) and the increase in lesion size (p<0.001) was associated with significantly longer delay. CONCLUSIONS: The study provides essential information for developing education campaigns in the future involving awareness promotion related to lesions perceived as minor significance. The present study emphasizes the importance of mindfulness and skills in the early detection of tumors. Prevention should be a decisive factor in primary care.
Conference/Value in Health Info
2015-05, ISPOR 2015, Philadelphia, PA, USA
Value in Health, Vol. 18, No. 3 (May 2015)
Code
PSS27
Topic
Economic Evaluation, Patient-Centered Research
Topic Subcategory
Stated Preference & Patient Satisfaction, Work & Home Productivity - Indirect Costs
Disease
Sensory System Disorders